Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
The global small-joint reconstructive implant market will experience rapid growth over the forecast period, driven by high growth in certain subsegments, such as those for shoulder and total ankle arthroplasty. Adoption of small-joint reconstructive implants is rising due to favorable clinical results and an expanding pool of trained surgeons, while high product ASPs, supported by ongoing product innovation and comparatively low pricing pressure in this underpenetrated market, will further contribute to strong revenue expansion.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the global market for small-joint reconstructive implants across a 10-year period.
Technological innovation will have a significant impact on the global small-joint reconstructive implant market.
How will new products address unmet clinical needs, and how will the launch of these implants impact the market?
How are companies reacting to the trends surrounding navigation technologies and personalized implants?
How important is clinical data to the adoption of newer materials and technologies in this space, given the large number of recalls and debatable outcomes associated with certain implants?
The shoulder and ankle arthroplasty segments exhibited strong growth in 2018.
What factors are driving procedure volume and revenue growth in these segments?
Which companies lead these segments and what are the innovations they are focusing on?
Which subsegments within shoulder arthroplasty are generating manufacturer interest?
Some technologies being launched in the small-joint reconstructive implant market have steep learning curves.
What strategies are companies using to increase the penetration of these technologies?
How can these technologies compete with established alternatives currently on the market?
As the market shifts toward value-based incentives, health care providers and orthopedic manufacturers are adopting new strategies to improve patient outcomes based on total episodes of care.
What are the current purchasing priorities of health care facilities?
How are health care facilities adding value to preoperative and postoperative care?
What strategies and added services are orthopedic manufacturers adopting in response to shifting hospital demands?
Already a Client? Log in to access this report.
Mohith Unny is a senior analyst within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Decision Resources Group, focusing on the joint reconstruction, trauma, orthopedic extremities, and hyaluronic acid viscosupplementation markets. Additionally, Mohith has led custom research projects for major orthopedic device companies, hosted webinars on behalf of DRG, and collaborated on thought leadership articles with industry consortiums such as AdvaMed. Mohith holds a Master's degree in Advanced Chemical Engineering from Imperial College London and was awarded the Prof. Geoffrey F. Hewitt Prize 2014/15.